Global and China Prescription Dermatological Medications Industry Market Research Report (2017-2028)

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Dermatology diseases includes common skin rashes to severe skin infections, which occurs due to range of things, such as infections, heat, allergens, system disorders and medications.

    This report elaborates on the current development of the Prescription Dermatological Medications industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Bausch Health

    • Galderma

    • Pfizer

    • PharmaDerm

    • Mylan Pharmaceuticals

    • Barrier Therapeutics

    • Novartis

    • Almirall

    • Bristol-Myers Squibb

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Oral

    • Topical

    Application:

    • Hospital Pharmacies

    • Online Pharmacies

    • Retail Pharmacies

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Prescription Dermatological Medications Industry Overview

      • 1.1.1 Prescription Dermatological Medications Market Scope and Market Segments

      • 1.1.2 Prescription Dermatological Medications Industry Characteristics

      • 1.1.3 Global and China Prescription Dermatological Medications Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Prescription Dermatological Medications Production Value and Growth Rate (2017-2028)

    • 1.2 Global Prescription Dermatological Medications Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Oral

      • 1.2.2 Topical

    • 1.3 Global Prescription Dermatological Medications Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospital Pharmacies

      • 1.3.2 Online Pharmacies

      • 1.3.3 Retail Pharmacies

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Prescription Dermatological Medications Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Prescription Dermatological Medications Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Prescription Dermatological Medications Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Prescription Dermatological Medications Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Prescription Dermatological Medications Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Prescription Dermatological Medications Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Prescription Dermatological Medications Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Prescription Dermatological Medications Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Prescription Dermatological Medications Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Prescription Dermatological Medications Industry Porter's Five Forces Model Analysis

      • 2.2.3 Prescription Dermatological Medications Industry PEST Analysis

    • 2.3 Prescription Dermatological Medications Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Prescription Dermatological Medications Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Prescription Dermatological Medications Industry

    Chapter 3 Global and China Prescription Dermatological Medications Market, by Manufacturer

    • 3.1 Global and China Prescription Dermatological Medications Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Prescription Dermatological Medications Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Prescription Dermatological Medications Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Prescription Dermatological Medications Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Prescription Dermatological Medications Market Top 3 Players

    Chapter 4 Global and China Prescription Dermatological Medications Market, by Type (2017-2028)

    • 4.1 Prescription Dermatological Medications Market Trend, by Type

    • 4.2 Global Prescription Dermatological Medications Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Prescription Dermatological Medications Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Prescription Dermatological Medications Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Prescription Dermatological Medications Price Trend, by Type (2017-2028)

    • 4.3 China Prescription Dermatological Medications Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Prescription Dermatological Medications Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Prescription Dermatological Medications Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Prescription Dermatological Medications Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Prescription Dermatological Medications Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Prescription Dermatological Medications Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Prescription Dermatological Medications Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Prescription Dermatological Medications Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Prescription Dermatological Medications Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Prescription Dermatological Medications Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Prescription Dermatological Medications Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Prescription Dermatological Medications Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Prescription Dermatological Medications Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Prescription Dermatological Medications Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Prescription Dermatological Medications Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Prescription Dermatological Medications Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Prescription Dermatological Medications Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Prescription Dermatological Medications Market Analysis

    • 7.1 North America Prescription Dermatological Medications Market, by Type

    • 7.2 North America Prescription Dermatological Medications Market, by Application

    • 7.3 North America Prescription Dermatological Medications Market Analysis and Forecast, by Country

      • 7.3.1 United States Prescription Dermatological Medications Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Prescription Dermatological Medications Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Prescription Dermatological Medications Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Prescription Dermatological Medications Market Analysis

    • 8.1 Europe Prescription Dermatological Medications Market, by Type

    • 8.2 Europe Prescription Dermatological Medications Market, by Application

    • 8.3 Europe Prescription Dermatological Medications Market Analysis and Forecast, by Country

      • 8.3.1 Germany Prescription Dermatological Medications Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Prescription Dermatological Medications Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Prescription Dermatological Medications Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Prescription Dermatological Medications Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Prescription Dermatological Medications Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Prescription Dermatological Medications Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Prescription Dermatological Medications Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Prescription Dermatological Medications Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Prescription Dermatological Medications Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Prescription Dermatological Medications Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Prescription Dermatological Medications Market Analysis

    • 9.1 APAC Prescription Dermatological Medications Market, by Type

    • 9.2 APAC Prescription Dermatological Medications Market, by Application

    • 9.3 APAC Prescription Dermatological Medications Market Analysis and Forecast, by Country

      • 9.3.1 China Prescription Dermatological Medications Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Prescription Dermatological Medications Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Prescription Dermatological Medications Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Prescription Dermatological Medications Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Prescription Dermatological Medications Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Prescription Dermatological Medications Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Prescription Dermatological Medications Market Analysis

    • 10.1 Latin America, Middle East and Africa Prescription Dermatological Medications Market, by Type

    • 10.2 Latin America, Middle East and Africa Prescription Dermatological Medications Market, by Application

    • 10.3 Latin America, Middle East and Africa Prescription Dermatological Medications Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Prescription Dermatological Medications Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Prescription Dermatological Medications Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Prescription Dermatological Medications Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Prescription Dermatological Medications Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Prescription Dermatological Medications Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Prescription Dermatological Medications Company Profiles

      • 11.1 Bausch Health

        • 11.1.1 Bausch Health Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Bausch Health Prescription Dermatological Medications Product Profiles, Application and Specification

        • 11.1.3 Bausch Health Prescription Dermatological Medications Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Galderma

        • 11.2.1 Galderma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Galderma Prescription Dermatological Medications Product Profiles, Application and Specification

        • 11.2.3 Galderma Prescription Dermatological Medications Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Pfizer

        • 11.3.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Pfizer Prescription Dermatological Medications Product Profiles, Application and Specification

        • 11.3.3 Pfizer Prescription Dermatological Medications Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 PharmaDerm

        • 11.4.1 PharmaDerm Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 PharmaDerm Prescription Dermatological Medications Product Profiles, Application and Specification

        • 11.4.3 PharmaDerm Prescription Dermatological Medications Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Mylan Pharmaceuticals

        • 11.5.1 Mylan Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Mylan Pharmaceuticals Prescription Dermatological Medications Product Profiles, Application and Specification

        • 11.5.3 Mylan Pharmaceuticals Prescription Dermatological Medications Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Barrier Therapeutics

        • 11.6.1 Barrier Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Barrier Therapeutics Prescription Dermatological Medications Product Profiles, Application and Specification

        • 11.6.3 Barrier Therapeutics Prescription Dermatological Medications Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Novartis

        • 11.7.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Novartis Prescription Dermatological Medications Product Profiles, Application and Specification

        • 11.7.3 Novartis Prescription Dermatological Medications Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Almirall

        • 11.8.1 Almirall Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Almirall Prescription Dermatological Medications Product Profiles, Application and Specification

        • 11.8.3 Almirall Prescription Dermatological Medications Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Bristol-Myers Squibb

        • 11.9.1 Bristol-Myers Squibb Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Bristol-Myers Squibb Prescription Dermatological Medications Product Profiles, Application and Specification

        • 11.9.3 Bristol-Myers Squibb Prescription Dermatological Medications Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Prescription Dermatological Medications Industry Investment Prospect and Risk Assessment

    • 12.1 Prescription Dermatological Medications Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Prescription Dermatological Medications Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Prescription Dermatological Medications Sales Volume and Growth Rate (2017-2028)

    • Figure China Prescription Dermatological Medications Sales Volume and Growth Rate (2017-2028)

    • Figure Global Prescription Dermatological Medications Production Value and Growth Rate (2017-2028)

    • Figure China Prescription Dermatological Medications Production Value and Growth Rate (2017-2028)

    • Figure Global Prescription Dermatological Medications Market Size and Growth Rate of Oral (2017-2028)

    • Figure Global Prescription Dermatological Medications Market Size and Growth Rate of Topical (2017-2028)

    • Figure Global Prescription Dermatological Medications Market Size and Growth Rate of Hospital Pharmacies (2017-2028)

    • Figure Global Prescription Dermatological Medications Market Size and Growth Rate of Online Pharmacies (2017-2028)

    • Figure Global Prescription Dermatological Medications Market Size and Growth Rate of Retail Pharmacies (2017-2028)

    • Figure North America Prescription Dermatological Medications Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Prescription Dermatological Medications Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Prescription Dermatological Medications Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Prescription Dermatological Medications Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Prescription Dermatological Medications Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Prescription Dermatological Medications Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Prescription Dermatological Medications Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Prescription Dermatological Medications Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Prescription Dermatological Medications Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Prescription Dermatological Medications Market Share, by Manufacturer in 2021

    • Figure Global and China Prescription Dermatological Medications Market Share, by Manufacturer in 2022

    • Table Global Prescription Dermatological Medications Sales Volume, by Type (2017-2028)

    • Table Global Prescription Dermatological Medications Sales Volume Share, by Type (2017-2028)

    • Figure Global Prescription Dermatological Medications Sales Volume Share, by Type (2017-2028)

    • Table Global Prescription Dermatological Medications Sales Value, by Type (2017-2028)

    • Table Global Prescription Dermatological Medications Sales Value Share, by Type (2017-2028)

    • Figure Global Prescription Dermatological Medications Price Trend, by Type (2017-2028)

    • Table China Prescription Dermatological Medications Sales Volume, by Type (2017-2028)

    • Table China Prescription Dermatological Medications Sales Volume Share, by Type (2017-2028)

    • Figure China Prescription Dermatological Medications Sales Volume Share, by Type (2017-2028)

    • Table China Prescription Dermatological Medications Sales Value, by Type (2017-2028)

    • Table China Prescription Dermatological Medications Sales Value Share, by Type (2017-2028)

    • Figure China Prescription Dermatological Medications Price Trend, by Type (2017-2028)

    • Table Global Prescription Dermatological Medications Sales Volume, by Application (2017-2028)

    • Table Global Prescription Dermatological Medications Sales Volume Share, by Application (2017-2028)

    • Figure Global Prescription Dermatological Medications Sales Volume Share, by Application (2017-2028)

    • Table Global Prescription Dermatological Medications Sales Value, by Application (2017-2028)

    • Table Global Prescription Dermatological Medications Sales Value Share, by Application (2017-2028)

    • Figure Global Prescription Dermatological Medications Sales Value Share, by Application (2017-2028)

    • Table China Prescription Dermatological Medications Sales Volume, by Application (2017-2028)

    • Table China Prescription Dermatological Medications Sales Volume Share, by Application (2017-2028)

    • Figure China Prescription Dermatological Medications Sales Volume Share, by Application (2017-2028)

    • Table China Prescription Dermatological Medications Sales Value, by Application (2017-2028)

    • Table China Prescription Dermatological Medications Sales Value Share, by Application (2017-2028)

    • Figure China Prescription Dermatological Medications Sales Value Share, by Application (2017-2028)

    • Figure China Prescription Dermatological Medications Production, Import, Consumption and Export (2017-2022)

    • Figure North America Prescription Dermatological Medications Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Prescription Dermatological Medications Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Prescription Dermatological Medications Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Prescription Dermatological Medications Production, Import, Consumption and Export (2017-2022)

    • Table North America Prescription Dermatological Medications Sales Volume, by Type (2017-2028)

    • Table North America Prescription Dermatological Medications Sales Volume Share, by Type (2017-2028)

    • Figure North America Prescription Dermatological Medications Sales Volume Share, by Type (2017-2028)

    • Table North America Prescription Dermatological Medications Sales Volume, by Application (2017-2028)

    • Table North America Prescription Dermatological Medications Sales Volume Share, by Application (2017-2028)

    • Figure North America Prescription Dermatological Medications Sales Volume Share, by Application (2017-2028)

    • Figure United States Prescription Dermatological Medications Sales Volume and Growth Rate (2017-2028)

    • Figure United States Prescription Dermatological Medications Sales Value and Growth Rate (2017-2028)

    • Figure Canada Prescription Dermatological Medications Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Prescription Dermatological Medications Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Prescription Dermatological Medications Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Prescription Dermatological Medications Sales Value and Growth Rate (2017-2028)

    • Table Europe Prescription Dermatological Medications Sales Volume, by Type (2017-2028)

    • Table Europe Prescription Dermatological Medications Sales Volume Share, by Type (2017-2028)

    • Figure Europe Prescription Dermatological Medications Sales Volume Share, by Type (2017-2028)

    • Table Europe Prescription Dermatological Medications Sales Volume, by Application (2017-2028)

    • Table Europe Prescription Dermatological Medications Sales Volume Share, by Application (2017-2028)

    • Figure Europe Prescription Dermatological Medications Sales Volume Share, by Application (2017-2028)

    • Figure Germany Prescription Dermatological Medications Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Prescription Dermatological Medications Sales Value and Growth Rate (2017-2028)

    • Figure UK Prescription Dermatological Medications Sales Volume and Growth Rate (2017-2028)

    • Figure UK Prescription Dermatological Medications Sales Value and Growth Rate (2017-2028)

    • Figure France Prescription Dermatological Medications Sales Volume and Growth Rate (2017-2028)

    • Figure France Prescription Dermatological Medications Sales Value and Growth Rate (2017-2028)

    • Figure Italy Prescription Dermatological Medications Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Prescription Dermatological Medications Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Prescription Dermatological Medications Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Prescription Dermatological Medications Sales Value and Growth Rate (2017-2028)

    • Figure Spain Prescription Dermatological Medications Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Prescription Dermatological Medications Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Prescription Dermatological Medications Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Prescription Dermatological Medications Sales Value and Growth Rate (2017-2028)

    • Figure Poland Prescription Dermatological Medications Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Prescription Dermatological Medications Sales Value and Growth Rate (2017-2028)

    • Figure Russia Prescription Dermatological Medications Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Prescription Dermatological Medications Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Prescription Dermatological Medications Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Prescription Dermatological Medications Sales Value and Growth Rate (2017-2028)

    • Table APAC Prescription Dermatological Medications Sales Volume, by Type (2017-2028)

    • Table APAC Prescription Dermatological Medications Sales Volume Share, by Type (2017-2028)

    • Figure APAC Prescription Dermatological Medications Sales Volume Share, by Type (2017-2028)

    • Table APAC Prescription Dermatological Medications Sales Volume, by Application (2017-2028)

    • Table APAC Prescription Dermatological Medications Sales Volume Share, by Application (2017-2028)

    • Figure APAC Prescription Dermatological Medications Sales Volume Share, by Application (2017-2028)

    • Figure China Prescription Dermatological Medications Sales Volume and Growth Rate (2017-2028)

    • Figure China Prescription Dermatological Medications Sales Value and Growth Rate (2017-2028)

    • Figure Japan Prescription Dermatological Medications Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Prescription Dermatological Medications Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Prescription Dermatological Medications Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Prescription Dermatological Medications Sales Value and Growth Rate (2017-2028)

    • Figure India Prescription Dermatological Medications Sales Volume and Growth Rate (2017-2028)

    • Figure India Prescription Dermatological Medications Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Prescription Dermatological Medications Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Prescription Dermatological Medications Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Prescription Dermatological Medications Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Prescription Dermatological Medications Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Prescription Dermatological Medications Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Prescription Dermatological Medications Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Prescription Dermatological Medications Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Prescription Dermatological Medications Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Prescription Dermatological Medications Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Prescription Dermatological Medications Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Prescription Dermatological Medications Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Prescription Dermatological Medications Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Prescription Dermatological Medications Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Prescription Dermatological Medications Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Prescription Dermatological Medications Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Prescription Dermatological Medications Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Prescription Dermatological Medications Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Prescription Dermatological Medications Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Prescription Dermatological Medications Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Prescription Dermatological Medications Sales Value and Growth Rate (2017-2028)

    • Table Bausch Health Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bausch Health Product Profiles, Application and Specification

    • Table Bausch Health Prescription Dermatological Medications Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Galderma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Galderma Product Profiles, Application and Specification

    • Table Galderma Prescription Dermatological Medications Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer Product Profiles, Application and Specification

    • Table Pfizer Prescription Dermatological Medications Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table PharmaDerm Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table PharmaDerm Product Profiles, Application and Specification

    • Table PharmaDerm Prescription Dermatological Medications Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Mylan Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Mylan Pharmaceuticals Product Profiles, Application and Specification

    • Table Mylan Pharmaceuticals Prescription Dermatological Medications Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Barrier Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Barrier Therapeutics Product Profiles, Application and Specification

    • Table Barrier Therapeutics Prescription Dermatological Medications Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novartis Product Profiles, Application and Specification

    • Table Novartis Prescription Dermatological Medications Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Almirall Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Almirall Product Profiles, Application and Specification

    • Table Almirall Prescription Dermatological Medications Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bristol-Myers Squibb Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bristol-Myers Squibb Product Profiles, Application and Specification

    • Table Bristol-Myers Squibb Prescription Dermatological Medications Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.